Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in alzheimer's disease

Anna Sokolova, Michelle D. Hill, Farid Rahimi, Lolita A. Warden, Glenda M. Halliday, Claire E. Shepherd

Research output: Contribution to journalArticlepeer-review

206 Citations (Scopus)

Abstract

Chronic neuroinflammation correlates with cognitive decline and brain atrophy in Alzheimer's disease (AD), and cytokines and chemokines mediate the inflammatory response. However, quantitation of cytokines and chemokines in AD brain tissue has only been carried out for a small number of mediators with variable results. We simultaneously quantified 17 cytokines and chemokines in brain tissue extracts from controls (n = 10) and from patients with and without genetic forms of AD (n = 12). Group comparisons accounting for multiple testing revealed that monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and interleukin-8 (IL-8) were consistently upregulated in AD brain tissue. Immunohistochemistry for MCP-1, IL-6 and IL-8 confirmed this increase and determined localization of these factors in neurons (MCP-1, IL-6, IL-8), astrocytes (MCP-1, IL-6) and plaque pathology (MCP-1, IL-8). Logistic linear regression modeling determined that MCP-1 was the most reliable predictor of disease. Our data support previous work on significant increases in IL-6 and IL-8 in AD but indicate that MCP-1 may play a more dominant role in chronic inflammation in AD.

Original languageEnglish
Pages (from-to)392-398
Number of pages7
JournalBrain Pathology
Volume19
Issue number3
DOIs
Publication statusPublished - Jul 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in alzheimer's disease'. Together they form a unique fingerprint.

Cite this